← Back
Data updated: Mar 10, 2026
MSN
OncologyCardiovascularNeurology
MSN is a generic drug manufacturer focused on Oncology, Cardiovascular, Neurology. Key products include CARMUSTINE.
2017
Since
90
Drugs
-
Trials
976
Approved (2yr)
Key Drugs
OLUMIANT
baricitinib
JAK1 3 indications · 2018
SACUBITRIL AND VALSARTAN
sacubitril
AT1 receptor 2 indications · 2024
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
linagliptin
DPP-4 1 indications · 2021
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide
AT1 receptor 1 indications · 2016
TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE
tipiracil hydrochloride
· 2023
Recent Activity
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
PREGABALIN 2026-02-24
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
PREGABALIN 2026-02-23
Labeling
BRIVARACETAM 2026-02-23
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 33%
12 drugs
Cardiovascular 28%
10 drugs
Neurology 17%
6 drugs
Respiratory 11%
4 drugs
Gastroenterology 11%
4 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Active (59)
PERAMPANEL RIVAROXABAN LOFEXIDINE HYDROCHLORIDE SACUBITRIL AND VALSARTAN ELTROMBOPAG OLAMINE NILOTINIB HYDROCHLORIDE LISDEXAMFETAMINE DIMESYLATE PLERIXAFOR SAFINAMIDE MESYLATE TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE TASIMELTEON BRIVARACETAM IVABRADINE HYDROCHLORIDE NELARABINE LINAGLIPTIN LINAGLIPTIN AND METFORMIN HYDROCHLORIDE SUNITINIB MALATE MACITENTAN TOLVAPTAN DABIGATRAN ETEXILATE MESYLATE MIRABEGRON ZIPRASIDONE MESYLATE POSACONAZOLE TOREMIFENE CITRATE ABIRATERONE ACETATE CARMUSTINE TICAGRELOR TERIFLUNOMIDE ROFLUMILAST OLUMIANT TRIENTINE HYDROCHLORIDE DARUNAVIR CLOFARABINE VIGABATRIN SILODOSIN OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE OSELTAMIVIR PHOSPHATE RUFINAMIDE ROSUVASTATIN CALCIUM DEFERASIROX ERLOTINIB HYDROCHLORIDE SOLIFENACIN SUCCINATE MOXIFLOXACIN HYDROCHLORIDE SIROLIMUS CAPECITABINE DECITABINE IRBESARTAN ATORVASTATIN CALCIUM LEVETIRACETAM DEXRAZOXANE HYDROCHLORIDE NOREPINEPHRINE BITARTRATE FAMOTIDINE ACYCLOVIR BUMETANIDE FLUPHENAZINE DECANOATE AMINOCAPROIC ACID DOXEPIN HYDROCHLORIDE THIOTEPA
Discontinued (25)
PREGABALIN GLYCOPYRROLATE PRUCALOPRIDE SUCCINATE ARSENIC TRIOXIDE LACOSAMIDE ISOSULFAN BLUE CHLORPROMAZINE HYDROCHLORIDE LOSARTAN POTASSIUM HALOPERIDOL FLUPHENAZINE HYDROCHLORIDE PYRIDOSTIGMINE BROMIDE FEBUXOSTAT CLOPIDOGREL BISULFATE PACLITAXEL PIRFENIDONE FOSAPREPITANT DIMEGLUMINE APREMILAST VALGANCICLOVIR HYDROCHLORIDE DOFETILIDE CLOBAZAM DIMETHYL FUMARATE PRAZOSIN HYDROCHLORIDE ALBENDAZOLE OBETICHOLIC ACID TIAGABINE HYDROCHLORIDE
Company Info
- First Approval
- 2017-09-22
- Latest
- 2026-02-23
- Applications
- 105